There have been 50 recent insider transactions recorded for Rezolute, Inc. (RZLT), including 45 buys and 3 sells. Total insider buying was valued at $10.56M and total insider selling at $150.98K.
Notable insiders with recent activity include Evans Daron, Elam Nevan C, Roberts Brian Kenneth. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — RZLT
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-30 |
Evans Daron |
CFO |
Informative Buy |
10,000 |
$2.85 |
$28.5K |
414,462 |
| 2026-03-02 |
Elam Nevan C |
CEO |
Tax Withholding of RSU |
27,618 |
$2.99 |
$82.58K |
613,501 |
| 2026-03-02 |
Evans Daron |
CFO |
Tax Withholding of RSU |
11,438 |
$2.99 |
$34.2K |
404,462 |
| 2026-03-02 |
Roberts Brian Kenneth |
Chief Medical Officer |
Tax Withholding of RSU |
11,439 |
$2.99 |
$34.2K |
296,913 |
| 2025-12-16 |
Hogenhuis Wladimir |
Director |
Informative Buy |
5,650 |
$1.69 |
$9.55K |
119,675 |
| 2025-12-16 |
Roberts Brian Kenneth |
Chief Medical Officer |
Informative Buy |
28,000 |
$1.70 |
$47.6K |
308,352 |
| 2025-12-15 |
Elam Nevan C |
CEO |
Informative Buy |
32,000 |
$1.59 |
$50.88K |
641,119 |
| 2025-12-15 |
Evans Daron |
CFO |
Informative Buy |
2,500 |
$1.79 |
$4.46K |
7,000 |
| 2025-12-15 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
Informative Buy |
12,000 |
$1.62 |
$19.44K |
71,442 |
| 2025-12-09 |
Evans Daron |
CFO |
Informative Buy |
10,549 |
$5.04 |
$53.17K |
131,900 |
| 2025-11-19 |
Elam Nevan C |
CEO |
RSU Award |
186,000 |
$10.16 |
$1.89M |
186,000 |
| 2025-11-19 |
Labrucherie Gil M |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Evans Daron |
CFO |
RSU Award |
63,000 |
$10.16 |
$640.08K |
63,000 |
| 2025-11-19 |
Kreher Nerissa |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Hogenhuis Wladimir |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Kim Young-jin |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Harris Erik |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Fauchet Philippe |
Director |
RSU Award |
12,000 |
$10.16 |
$121.92K |
12,000 |
| 2025-11-19 |
Roberts Brian Kenneth |
Chief Medical Officer |
Acquisition |
72,000 |
$10.16 |
$731.52K |
72,000 |
| 2025-11-19 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
RSU Award |
19,000 |
$10.16 |
$193.04K |
19,000 |
| 2025-08-18 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
Unknown |
- |
- |
- |
1,898 |
| 2025-08-18 |
Karnawat Sunil Ratilal |
Chief Commercial Officer |
RSU Award |
25,000 |
- |
- |
27,442 |
| 2025-06-25 |
Roberts Brian Kenneth |
Chief Medical Officer |
Informative Buy |
2,500 |
$4.38 |
$10.94K |
15,500 |
| 2025-06-24 |
Evans Daron |
CFO |
Informative Buy |
5,000 |
$4.05 |
$20.25K |
268,900 |
| 2025-06-13 |
Kreher Nerissa |
Director |
Informative Buy |
3,076 |
$3.25 |
$10K |
37,576 |
| 2025-06-13 |
Kim Young-jin |
Director |
Informative Buy |
1,230,769 |
$3.25 |
$4M |
8,423,386 |
| 2025-06-10 |
Elam Nevan C |
CEO |
RSU Award |
40,000 |
$4.39 |
$175.6K |
40,000 |
| 2025-06-10 |
Evans Daron |
CFO |
RSU Award |
15,000 |
$4.39 |
$65.85K |
15,000 |
| 2025-06-10 |
Kim Young-jin |
Director |
RSU Award |
5,000 |
$4.39 |
$21.95K |
5,000 |
| 2025-06-10 |
Fauchet Philippe |
Director |
RSU Award |
5,000 |
$4.39 |
$21.95K |
5,000 |
| 2025-06-10 |
Roberts Brian Kenneth |
Chief Medical Officer |
RSU Award |
15,000 |
$4.39 |
$65.85K |
15,000 |
| 2025-06-10 |
Labrucherie Gil M |
Director |
RSU Award |
5,000 |
$4.39 |
$21.95K |
5,000 |
| 2025-06-10 |
Kreher Nerissa |
Director |
RSU Award |
5,000 |
$4.39 |
$21.95K |
5,000 |
| 2025-06-10 |
Hogenhuis Wladimir |
Director |
RSU Award |
5,000 |
$4.39 |
$21.95K |
5,000 |
| 2025-03-31 |
Hogenhuis Wladimir |
Director |
Informative Buy |
6,758 |
$2.92 |
$19.73K |
84,025 |
| 2025-03-27 |
Elam Nevan C |
CEO |
Informative Buy |
12,302 |
$2.85 |
$35K |
224,119 |
| 2025-03-26 |
Evans Daron |
CFO |
Informative Buy |
10,000 |
$2.88 |
$28.8K |
23,000 |
| 2025-03-25 |
Harris Erik |
Officer |
Unknown |
- |
- |
- |
- |
| 2025-03-25 |
Harris Erik |
Director |
RSU Award |
60,000 |
$2.89 |
$173.4K |
60,000 |
| 2025-02-18 |
Hogenhuis Wladimir |
Director |
Informative Buy |
10,000 |
$4.70 |
$47K |
77,267 |
| 2025-02-16 |
Elam Nevan C |
CEO |
RSU Award |
120,000 |
$4.61 |
$553.2K |
120,000 |
| 2025-02-16 |
Evans Daron |
CFO |
RSU Award |
45,000 |
$4.61 |
$207.45K |
45,000 |
| 2025-02-16 |
Kreher Nerissa |
Director |
RSU Award |
15,000 |
$4.61 |
$69.15K |
15,000 |
| 2025-02-16 |
Kim Young-jin |
Director |
RSU Award |
15,000 |
$4.61 |
$69.15K |
15,000 |
| 2025-02-16 |
Fauchet Philippe |
Director |
RSU Award |
15,000 |
$4.61 |
$69.15K |
15,000 |
| 2025-02-16 |
Roberts Brian Kenneth |
Chief Medical Officer |
RSU Award |
45,000 |
$4.61 |
$207.45K |
45,000 |
| 2025-02-16 |
Labrucherie Gil M |
Director |
RSU Award |
15,000 |
$4.61 |
$69.15K |
15,000 |
| 2025-02-16 |
Hogenhuis Wladimir |
Director |
RSU Award |
15,000 |
$4.61 |
$69.15K |
15,000 |
| 2024-12-18 |
Evans Daron |
CFO |
Informative Buy |
10,000 |
$4.29 |
$42.9K |
150,900 |
| 2024-12-12 |
Evans Daron |
CFO |
Informative Buy |
9,000 |
$4.60 |
$41.4K |
140,900 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
